Osage University Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 14
- Investments
- 167
- Portfolio
- 62
- Exits
- 45
Osage University Partners General Information
Description
Founded in 1905, Osage University Partners is a venture capital firm based in Bala Cynwyd, Pennsylvania. The firm focuses on investing in startups that are commercializing university technologies. Osage prefers to partner with research universities to invest in their innovative startups sharing their investment profit with partner institutions. The firm seeks to invest in the software, hardware and life science companies at all stages of company development.
Contact Information
Website
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 50 Monument Road
- Suite 201
- Bala Cynwyd, PA 19004
- United States
+1 (484) 000-0000
Osage University Partners Investments (167)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| DiCE Molecules | 08-Jan-2021 | Later Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 000000 0000000 | 07-Jan-2021 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | 0000000 0000000000 00 |
| 000000 00000000000 | 16-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | |
| 00000000 | 09-Dec-2020 | 0000 00000 | 000 | Business/Productivity Software | Generating Revenue | |
| 00000 00000000 | 12-Nov-2020 | 00000 00000 | 00000 | Network Management Software | Generating Revenue | |
| 000 000 | 29-Oct-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | |
| 00000000 000000000 | 25-Sep-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 000000 000 | 14-Sep-2020 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | |
| Escient Pharmaceuticals | 25-Aug-2020 | Early Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | |
| SiFive | 11-Aug-2020 | Later Stage VC | 0000 | Application Specific Semiconductors | Generating Revenue |
Osage University Partners Exits (42)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| PMV Pharma | 25-Sep-2020 | IPO | 00000 |
| 00000000 | 04-Jun-2020 | 000000000000000000 | |
| 0000 000000000000 | 05-Feb-2020 | 000 | 00000 |
| 000000 000000 | 13-Dec-2019 | 0000000000: 000000 | |
| 0000000 0000000000 | 13-Sep-2019 | 000 | 000.00 |
| 00000 000000000000 | 09-Sep-2019 | 000000000000000000 | 00000 |
| 0000000 0000000 | 30-Apr-2019 | 0000000000 | |
| 000000000 00000000 | 28-Mar-2019 | 000 | 00000 |
| Jibo | 04-Mar-2019 | Out of Business | |
| Luxtera | 06-Feb-2019 | Merger/Acquisition | 00000 |
Osage University Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialOsage University Partners Team (24)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Marc Singer | Managing Partner, Technology & Co-Founder | 00 | 0 | 0 | Bala Cynwyd, PA |
| William Harrington MD | Managing Partner, Life Science | 00 | 0 | 0 | Bala Cynwyd, PA |
| Louis Berneman | Co-Founding Partner | Bala Cynwyd, PA | |||
| Matthew Cohen Ph.D | Partner, Life Science | 0 | 0 | 0 | Bala Cynwyd, PA |
| Kirsten Leute | Partner Of University Relations | Bala Cynwyd, PA |
Osage University Partners Co-Investors (295)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 8 | 0 | 0 |
|
|
| Alexandria Venture Investments | 0 | 0 |
|
|
|
| RA Capital Management | 0 | 0 | 0 |
|
|
| GV | 0 | 0 |
|
|
|
| Johnson & Johnson Innovation - JJDC | 0 | 0 |
|
|